SCHEMBL17434

SCHEMBL17434

CC1(C)C(=O)NCCN1C[C@@]1(c2ncc(C(O)(C(F)(F)F)C(F)(F)F)cn2)CN(S(=O)(=O)C2=CC(N)=CCC2=S)CCN1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 2/20 0.31
GCKR Q14397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16994 0.85 GCKR (0.30) GCKR
SCHEMBL29516 0.85 GCKR (0.30) GCKR
SCHEMBL17655 0.85 GCKR (0.30) GCKR
SCHEMBL17222 0.83 GCK (0.47) GCKGCKR
SCHEMBL16588 0.82 GCK (0.30) GCK
SCHEMBL16816 0.81 GCK (0.31) GCK
SCHEMBL16486 0.81 GCK (0.30) GCK
SCHEMBL16561 0.80 GCK (0.38) GCKGCKR
SCHEMBL16712 0.80 GCKR (0.41) GCKGCKR
SCHEMBL17404 0.80 RORC (0.32) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed